07/17/2014 09:09 EDT | Updated 09/16/2014 05:59 EDT

Nova Scotia expands coverage of treatment for chronic retina diseases

HALIFAX - Coverage in Nova Scotia is being expanded for treatment of chronic retina diseases that can cause blindness.

The provincial government says it will fund Lucentis and Avastin treatments in Yarmouth, Kentville and Bridgewater to cut down on travel time for patients.

The drugs treat diabetic macular edema, retinal vein occlusion and wet age-related macular degeneration.

Coverage has already started in Yarmouth and Kentville, while Bridgewater plans to begin offering funded treatments within the next month.

Halifax, Sydney and Antigonish already offer treatments.

Patients must be members of the seniors, family or community services pharmacare programs.